Most patients with migraine are women, and this observation is reflected in clinical studies. A pharmacologist and a neurologist from the United States argue that the efficacy of calcitonin ...
Meloxicam/Rizatriptan Effective in Migraine Patients With Inadequate Response to Oral CGRP Inhibitor
Findings showed meloxicam/rizatriptan statistically significantly improved migraine treatment response compared with prior oral CGRP inhibitor treatment. Topline data were announced from a phase 3 ...
SAN DIEGO -- Fremanezumab (Ajovy) cut monthly migraine days in children and adolescents with episodic migraine, according to the SPACE trial. The phase III study showed a reduction in monthly migraine ...
Internist Vincent Martin, MD, said every primary care clinician should know about calcitonin gene-related peptide (CGRP) monoclonal antibodies for preventing migraines. These newer drugs are changing ...
Please provide your email address to receive an email when new articles are posted on . A majority of patients had initial or sustained significant symptom improvement, with few adverse effects. Most ...
Senior Lecturer and Director of Headache Research, Consultant clinical scientist; King's College London and Guy's and St Thomas' NHS Trust, King's College London A drug that can help prevent migraines ...
Neurologist Dr. Susan Lee answers common questions about new treatments for migraine and where the future of migraine research is headed. Standard treatments taken at the onset of a migraine episode ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results